Copyright
©The Author(s) 2021.
World J Clin Oncol. Apr 24, 2021; 12(4): 262-271
Published online Apr 24, 2021. doi: 10.5306/wjco.v12.i4.262
Published online Apr 24, 2021. doi: 10.5306/wjco.v12.i4.262
Cases of liver tumor with triple differentiation described in the literature | Ref. |
Chinese male patients (n = 2; average age: 57.5 yr). Both were positive for hepatitis B and exhibited hepatic tumors with triple differentiation. | He et al[8], 2013 |
An otherwise healthy 19-year-old Caucasian male developed a large hepatic tumor showing triple differentiation. | Beard et al[7], 2017 |
A 65-year-old female with a previous history of hepatitis C and rectal “carcinoid” developed a hepatic tumor with triple differentiation. | Current case report |
Dates | Summary from initial and follow-up visits | Diagnostic testing | Intervention/results |
2012 and 2017 | Routine colonoscopy | 1 cm polypoid lesion in rectum | Removed endoscopically → well-differentiated neuroendocrine tumor |
May/June 2019 | Presents with abdominal pain | CT, MRI, FDG/PET → two liver lesions | CT-guided biopsy → poorly differentiated carcinoma with neuroendocrine features |
September 2019 | Presents for surgical intervention | Presents for surgical intervention | Resection of the 2 liver lesions → Final diagnosis of combined liver tumor |
October 2019 | Post-surgical follow-up | CT and FDG/PET → New liver lesion in dome | Additional imaging was advocated |
March 2020 | MRI revealed new portocaval lymphadenopathy | Endoscopic ultrasound-guided FNA of lymph nodes | Lymph nodes positive for metastatic adenocarcinoma |
May 2020 | Final oncology consultation after imaging | Initiation of cisplatin and gemcitabine chemotherapy | |
October 2020 | Presents to hospital with altered mental status | Found to be in shock due to a combination of GI bleed/sepsis | Patient expired, despite medical treatment |
- Citation: Dimopoulos YP, Winslow ER, He AR, Ozdemirli M. Hepatocellular carcinoma with biliary and neuroendocrine differentiation: A case report. World J Clin Oncol 2021; 12(4): 262-271
- URL: https://www.wjgnet.com/2218-4333/full/v12/i4/262.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i4.262